Nurse Practitioner, Primary Care · Little Rock, AR
NPI
1548749906
Since 2018
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
10001 Lile Dr
Little Rock, AR, 72205
Phone (501) 552-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
17,982 services
Medicare patients, 2024
191
Average age 72
Drug cost, 2024
$1.5M
1,742 prescriptions
Company payments, 2025
$16K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chelsea E Presson was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,210 times for 24 patients. In total Chelsea E Presson billed 17,982 services in 87 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,210 | 24 | $4.97 | $71K |
| A9576 Injection, gadoteridol, (prohance multipack), per ml | Office | 583 | 34 | $1.15 | $668 |
| J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg | Office | 395 | 23 | $0.01 | $3.68 |
| 99214 Office E&M - Established | Office | 390 | 154 | $72.05 | $28K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 351 | 24 | $0.73 | $257 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 272 | 151 | $10.06 | $2,735 |
| 36415 Venipuncture Blood Collection | Office | 132 | 109 | $8.65 | $1,142 |
| 83735 Clinical Chemistry | Office | 94 | 90 | $6.57 | $618 |
| 85025 Blood Count | Office | 84 | 79 | $7.61 | $639 |
| 80053 Clinical Chemistry | Office | 83 | 79 | $10.35 | $859 |
| 82607 Clinical Chemistry | Office | 82 | 78 | $14.78 | $1,212 |
| 82306 Clinical Chemistry | Office | 68 | 63 | $29.01 | $1,973 |
| 84443 Clinical Chemistry | Office | 67 | 66 | $16.46 | $1,103 |
| 64615 Musculoskeletal | Office | 63 | 22 | $80.82 | $5,092 |
| 83036 Blood Count | Office | 55 | 52 | $9.52 | $524 |
By year: 2022 $3,673 for 105 services; 2023 $80K for 9,651 services; 2024 $141K for 17,982 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 132 | 109 | $8.65 | $1,142 |
| 83735 Clinical Chemistry | 94 | 90 | $6.57 | $618 |
| 85025 Blood Count | 84 | 79 | $7.61 | $639 |
| 80053 Clinical Chemistry | 83 | 79 | $10.35 | $859 |
| 82607 Clinical Chemistry | 82 | 78 | $14.78 | $1,212 |
| 82306 Clinical Chemistry | 68 | 63 | $29.01 | $1,973 |
| 84443 Clinical Chemistry | 67 | 66 | $16.46 | $1,103 |
| 83036 Blood Count | 55 | 52 | $9.52 | $524 |
| 84439 Clinical Chemistry | 47 | 46 | $8.84 | $415 |
| 82746 Clinical Chemistry | 42 | 41 | $14.41 | $605 |
Medicare prescription drug claims, 2024
In 2024, the drug Chelsea E Presson prescribed most often to Medicare patients was Gabapentin, with 133 prescriptions and refills. In total Chelsea E Presson wrote 1,742 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 133 | 159 | 31 | $1,743 |
| Nortriptyline Hcl Generic | 129 | 181 | 38 | $2,010 |
| Ropinirole Hcl Generic | 88 | 105 | 21 | $1,794 |
| Escitalopram Oxalate Generic | 66 | 162 | 21 | $833 |
| Tizanidine Hcl Generic | 61 | 107 | 20 | $532 |
| Emgality Pen Galcanezumab-Gnlm | 60 | 93 | 11 | $67K |
| Nurtec Odt Rimegepant Sulfate | 48 | 56 | 17 | $83K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 47 | 77 | 21 | $1,152 |
| Donepezil Hcl Generic | 44 | 89 | 13 | $392 |
| Lamotrigine Generic | 41 | 60 | 15 | $733 |
| Verapamil Hcl Generic | 39 | 52 | Under 11 | $190 |
| Levetiracetam Generic | 38 | 62 | Under 11 | $1,430 |
| Propranolol Hcl Generic | 33 | 51 | Under 11 | $408 |
| Emgality Syringe Galcanezumab-Gnlm | 31 | 47 | Under 11 | $75K |
| Qulipta Atogepant | 30 | 32 | 11 | $34K |
Brand drugs: - claims; generic drugs: 1,373 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chelsea E Presson $16K ($16K in general payments such as food, travel and fees) from 27 companies. The largest payer was Pfizer Inc. with $9,507.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 24 | $9,507 |
| Argenx US, Inc. ARGX | 21 | $2,852 |
| Abbvie Inc. ABBV | 59 | $919 |
| UCB, Inc. UCB.BR | 16 | $407 |
| CSL Behring CSL.AX | 16 | $303 |
| MDD US Operations, LLC | 14 | $262 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $198 |
| Amneal Pharmaceuticals LLC AMRX | 18 | $152 |
| Lundbeck LLC | 10 | $138 |
| SpringWorks Therapeutics, Inc. | 4 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.